Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Haloperidol
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 04, 2021
Lead Product(s) : Haloperidol
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Farmovs
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 02, 2020
Lead Product(s) : Haloperidol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Farmovs
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Farmovs
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 02, 2020
Lead Product(s) : Haloperidol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Farmovs
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Haloperidol for Delirium in Adult Critically Ill Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 14, 2018
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Centre for Research in Intensive Care | Copenhagen Trial Unit, Center for Clinical Intervention Research | Scandinavian Critical Care Trials Group | The Danish Centre of Applied Social Science (VIVE)
Deal Size : Inapplicable
Deal Type : Inapplicable
Agents Intervening Against Delirium in Intensive Care Unit
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 08, 2018
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Centre for Research in Intensive Care | Copenhagen Trial Unit, Center for Clinical Intervention Research | Scandinavian Critical Care Trials Group | The Danish Centre of Applied Social Science (VIVE)
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 23, 2016
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 30, 2014
Lead Product(s) : Haloperidol
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 07, 2013
Lead Product(s) : Haloperidol
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Haloperidol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 29, 2011
Lead Product(s) : Haloperidol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable